CDTX — CIDARA THERAPEUTICS INC

Ownership history in SUPERSTRING CAPITAL MANAGEMENT LP  ·  2 quarters on record

This page tracks every 13F SEC filing in which SUPERSTRING CAPITAL MANAGEMENT LP reported a position in CIDARA THERAPEUTICS INC (CDTX). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
10.06% (2025 Q4)
Avg. % of fund
8.26%
First filed
2025 Q3
Last filed
2025 Q4
Quarters held
2
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 ADDED 85,098 +16,635 +24.3% 10.06% $18.8M —
2025 Q3 INITIATED 68,463 — — 6.46% $6.6M —
% of Fund (quarterly)

Other funds also holding CDTX

As of 2025 Q4 — sorted by position size

Velan Capital Investment Management LP 3Y 13.89% Vivo Capital, LLC 3Y 7Y 13.66% ACUTA CAPITAL PARTNERS, LLC 3Y 7Y 13.37% Beryl Capital Management LLC 3Y 7Y 11.69% FNY Investment Advisers, LLC 3Y 7Y 9.07% OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) 3Y 7Y 8.12% RA CAPITAL MANAGEMENT, L.P. 3Y 7Y 7.62% Sand Grove Capital Management LLP 3Y 7Y 6.05% Chicago Capital Management, LLC 3Y 7Y 5.56% Ikarian Capital, LLC 3Y 5.17%
← Back to SUPERSTRING CAPITAL MANAGEMENT LP Holdings